The phase 3 HYPERION trial of Winrevair in adults with newly diagnosed pulmonary arterial hypertension functional class two or three is ending early due to robust positive evidence found in previous ...

WESTLAKE VILLAGE, Calif. - Genelux Corporation (NASDAQ: GNLX), an immuno-oncology company in the late clinical stage with a market capitalization of $135 million, announced the appointment of Matthew ...

WESTLAKE VILLAGE, CA – Genelux Corporation (NASDAQ:GNLX), a clinical-stage pharmaceutical company with a market capitalization of $134.7 million, announced significant changes in its executive team.

Researchers at the Indian Institute of Technology, Guwahati, in partnership with leading institutions around the world, have ...

Sarfaraz K. Niazi, PhD, argues that regulatory agencies should eliminate redundant clinical efficacy testing for biosimilars, ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

Future development plans include incorporating AI, expanding connectors, and specializing in additional therapeutic areas.

Researchers at the Indian Institute of Technology (IIT) Guwahati, National University of Singapore and University of Michigan have developed an innovative multi-stage clinical trial method aimed at ...

When smart people make irrational choices, we often assume they are acting out of selfishness, stupidity or stubbornness.

Unsurprisingly, Akero owes this incredible one-day gain to data from a midstage clinical trial. Akero Therapeutics is ...

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...

Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...